Reuters logo
BRIEF-NovaBay Pharma sees FY 2017 sales $19 mln
2017年8月10日 / 晚上8点40分 / 3 个月前

BRIEF-NovaBay Pharma sees FY 2017 sales $19 mln

Aug 10 (Reuters) - NovaBay Pharmaceuticals Inc:

* NovaBay Pharmaceuticals reports second quarter 2017 financial results

* Q2 loss per share $0.11

* Sees FY 2017 sales $19 million

* Q2 sales $4.1 million versus I/B/E/S view $4.3 million

* Q2 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S

* NovaBay Pharmaceuticals Inc says NovaBay is affirming total sales and gross profit margin guidance for 2017 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below